These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14851702)

  • 1. Pseudomonas pyocyanea in burns; its role as a pathogen, and the value of local polymyxin therapy.
    JACKSON DM; LOWBURY EJ; TOPLEY E
    Lancet; 1951 Jul; 2(6674):137-47. PubMed ID: 14851702
    [No Abstract]   [Full Text] [Related]  

  • 2. ACUTE BACTERIAL ENDOCARDITIS DUE TO PSEUDOMONAS IN A BURNED PATIENT.
    ROBINSON OG; HOOPES JE; CONN JH; ARTZ CP
    Am Surg; 1964 Sep; 30():617-8. PubMed ID: 14209706
    [No Abstract]   [Full Text] [Related]  

  • 3. The action of polymyxin on Pseudomonas pyocyanea.
    NEWTON BA
    J Gen Microbiol; 1953 Feb; 8(1):vi-vii. PubMed ID: 13035059
    [No Abstract]   [Full Text] [Related]  

  • 4. SURFACE INFECTION WITH PSEUDOMONAS AERUGINOSA.
    WALKER HL; MASON AD; RAULSTON GL
    Ann Surg; 1964 Aug; 160(2):297-305. PubMed ID: 14209734
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudomonas pyocyanea meningitis successfully treated with polymyxin.
    TRAPNELL DH
    Lancet; 1954 Apr; 266(6815):759-61. PubMed ID: 13153108
    [No Abstract]   [Full Text] [Related]  

  • 6. The epidemiology of infection with Pseudomonas pyocyanea in a burns unit.
    LOWBURY EJ; FOX J
    J Hyg (Lond); 1954 Sep; 52(3):403-16. PubMed ID: 13212044
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic combinations of polymyxins.
    Lenhard JR; Nation RL; Tsuji BT
    Int J Antimicrob Agents; 2016 Dec; 48(6):607-613. PubMed ID: 27865626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POLYMYXIN B AND COLISTIN: IN VITRO ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA.
    EICKHOFF TC; FINLAND M
    Am J Med Sci; 1965 Feb; 249():172-4. PubMed ID: 14257308
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
    van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The release of soluble constituents from washed cells of Pseudomonas aeruginosa by the action of polymyxin.
    NEWTON BA
    J Gen Microbiol; 1953 Aug; 9(1):54-64. PubMed ID: 13084878
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymyxin-Induced Lipid A Deacylation in Pseudomonas aeruginosa Perturbs Polymyxin Penetration and Confers High-Level Resistance.
    Han ML; Velkov T; Zhu Y; Roberts KD; Le Brun AP; Chow SH; Gutu AD; Moskowitz SM; Shen HH; Li J
    ACS Chem Biol; 2018 Jan; 13(1):121-130. PubMed ID: 29182311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the gene encoding monothiol glutaredoxin (GrxD) in Pseudomonas aeruginosa increases its susceptibility to polymyxins.
    Romsang A; Leesukon P; Duangnkern J; Vattanaviboon P; Mongkolsuk S
    Int J Antimicrob Agents; 2015 Mar; 45(3):314-8. PubMed ID: 25593012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas meningitis; report of a case with recovery after polymyxin B therapy.
    TOMLIN CE
    AMA Arch Intern Med; 1951 Jun; 87(6):863-7. PubMed ID: 14829091
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study.
    Lipový B; Rihová H; Hanslianová M; Gregorová N; Suchánek I; Brychta P
    Acta Chir Plast; 2010; 52(2-4):39-43. PubMed ID: 21749009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Step-wise resistance to polymyxin and other agents by Pseudomonas aeruginosa.
    Brown MR; Watkins WM; Foster JH
    J Gen Microbiol; 1969 Mar; 55(3):17-8. PubMed ID: 4307650
    [No Abstract]   [Full Text] [Related]  

  • 16. [CLINICAL STUDIES ON PSEUDOMONAS AERUGINOSA INFECTIONS. 2. ON THE SUSCEPTIBILITY OF PSEUDOMONAS AERUGINOSA TO ANTIBIOTICS, WITH SPECIAL REFERENCE TO COLISTIN].
    TAKIGAMI T; TANI S; KITAMOTO O
    Nihon Densenbyo Gakkai Zasshi; 1964 Feb; 37():401-8. PubMed ID: 14126272
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for isolation of strains susceptible only to polymyxin among patients with Pseudomonas aeruginosa bacteremia.
    Falagas ME; Koletsi PK; Kopterides P; Michalopoulos A
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2541-3. PubMed ID: 16801440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pyocin types and proteolytic properties of Pseudomonas pyocyanea organisms in burned patients and in the milieu of the Division of Burns, Institute of Hematology in Warsaw].
    Bukowska D; Serafińska D; Nasilowski W; Zietkiewicz W
    Pol Tyg Lek; 1976 Jun; 31(26):1107-10. PubMed ID: 821048
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudomonas aeruginosa high-level resistance to polymyxins and other antimicrobial peptides requires cprA, a gene that is disrupted in the PAO1 strain.
    Gutu AD; Rodgers NS; Park J; Moskowitz SM
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5377-87. PubMed ID: 26100714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on combined effect of polymyxin and tetracycline on Pseudomonas aeruginosa infection in white mice].
    RUBTSOVA LK
    Antibiotiki (Mosc); 1958; 3(5):83-6. PubMed ID: 24545109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.